The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration
Open accessThe DOI matches its Crossref record; 175 of the 177 references it cites were found in a registry or an index.
Abstract
Understanding the molecular underpinnings of neurodegeneration processes is a pressing challenge for medicine and neurobiology. Alzheimer’s disease (AD) and Parkinson’s disease (PD) represent the most prevalent forms of neurodegeneration. To date, a substantial body of experimental evidence has strongly implicated hypoxia in the pathogenesis of numerous neurological disorders, including AD, PD, and other age-related neurodegenerative conditions. Hypoxia-inducible factor (HIF) is a transcription factor that triggers a cell survival program in conditions of oxygen deprivation. The involvement of HIF-1α in neurodegenerative processes presents a complex and sometimes contradictory picture. This review aims to elucidate the current understanding of the interplay between hypoxia and the development of AD and PD, assess the involvement of HIF-1 in their pathogenesis, and summarize promising therapeutic approaches centered on modulating the activity of the HIF-1 complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, chronic hypoxia is thought to trigger α-syn phosphorylation and aggregation, which interacts with hypoxia-induced mitochondrial dysfunction to worsen PD progression.265”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [265]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“An essential aspect concerning the involvement of HIF-1 in pathogenesis pertains to its impact on inflammatory mechanisms.”
BackgroundMutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874 · cited 1×
“Parkinson’s disease (PD) ranks as the second most common neurodegenerative disorder [5], representing the fore-most serious movement disorder globally.”
BackgroundHIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · cited 2×
“Consequently, PHD activity can be hindered by small molecules either indirectly (noncompetitively), through reducing the cellular levels of oxygen, iron, or 2-oxoglutarate, or directly (competitively) via compounds binding to and obstructing the 2-oxoglutarate-binding site.”
BackgroundOxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (2009) · Physiology · doi:10.1152/physiol.00045.2008 · Cited by 926
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Semenza, G. L. (2004) · Physiology · doi:10.1152/physiol.00001.2004 · Cited by 905
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., et al. (2017) · Science · doi:10.1126/science.aam9080 · Cited by 874
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 782
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
Di Maio, R., Barrett, P. J., Hoffman, E. K., Barrett, C. W., Zharikov, A., Borah, A., Hu, X., McCoy, J., Chu, C. T., Burton, E. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3634 · Cited by 619 · cited 2×
“…damage, contributing to the loss of dopaminergic cells in the substantia nigra PD is characterized by mitochondrial de fi cits, including a reduced mitochondrial number and structural damage, alongside diminished activity of complex I of the mitochondrial respiratory chain, potentially mediated…”
BackgroundChen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
The worldwide costs of dementia in 2019
Wimo, A., Seeher, K., Cataldi, R., Cyhlarova, E., Dielemann, J. L., Frisell, O., Guerchet, M., Jönsson, L., Malaha, A. K., Nichols, E., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12901 · Cited by 559
Pacelli, C., Giguère, N., Bourque, M.-J., Lévesque, M., Slack, R. S., & Trudeau, L.-É. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.050 · Cited by 530
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & Jelkmann, W. (1999) · Blood · doi:10.1182/blood.v94.5.1561 · Cited by 475
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 474
Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions
Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V. M.-Y., Trojanowski, J. Q., Mann, D., & Iwatsubo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208046200 · Cited by 428 · cited 1×
“Among these modifications, phosphorylation at the Ser129 site is considered a key event that promotes α -synuclein aggregation and subsequent pathology [59,60].”
BackgroundSleep-disordered breathing advances cognitive decline in the elderly
Osorio, R. S., Gumb, T., Pirraglia, E., Varga, A. W., Lu, S.-E., Lim, J., Wohlleber, M. E., Ducca, E. L., Koushyk, V., Glodzik, L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001566 · Cited by 427
Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.035 · Cited by 394
Transferrin Receptor Induction by Hypoxia
Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., & Cairo, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24142 · Cited by 379
Tello, D., Balsa, E., Acosta-Iborra, B., Fuertes-Yebra, E., Elorza, A., Ordóñez, Á., Corral-Escariz, M., Soro, I., López-Bernardo, E., Perales-Clemente, E., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.008 · Cited by 368
Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2015) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345
Alpha-synuclein oligomers: a new hope
Bengoa-Vergniory, N., Roberts, R. F., Wade-Martins, R., & Alegre-Abarrategui, J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1755-1 · Cited by 338
Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Burtscher, J., Mallet, R. T., Burtscher, M., & Millet, G. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101343 · Cited by 324
Hypoxia-inducible factors and obstructive sleep apnea
Prabhakar, N. R., Peng, Y.-J., & Nanduri, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137560 · Cited by 318
Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11444.x · Cited by 299
Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis
Wei, Z., Li, X., Li, X., Liu, Q., & Cheng, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00236 · Cited by 281
Glucose transporter 3 in neuronal glucose metabolism: Health and diseases
Peng, W., Tan, C., Mo, L., Jiang, J., Zhou, W., Du, J., Zhou, X., Liu, X., & Chen, L. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154869 · Cited by 278
Czyzyk-Krzeska, M. F., Furnari, B. A., Lawson, E. E., & Millhorn, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42415-x · Cited by 264
Soucek, T., Cumming, R., Dargusch, R., Maher, P., & Schubert, D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00367-2 · Cited by 258
Hypocretin (orexin) loss in Alzheimer's disease
Fronczek, R., van Geest, S., Frölich, M., Overeem, S., Roelandse, F. W. C., Lammers, G. J., & Swaab, D. F. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.014 · Cited by 254
Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., Colombatto, S., Danni, O., Parola, M., Smith, M. A., Perry, G., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05858.x · Cited by 243
Impaired Spatial Learning and Hyperactivity in Developing Rats Exposed to Intermittent Hypoxia
Row, B. W., Kheirandish, L., Neville, J. J., & Gozal, D. (2002) · Pediatric Research · doi:10.1203/00006450-200209000-00024 · Cited by 239
Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP
Li, L., Zhang, X., Yang, D., Luo, G., Chen, S., & Le, W. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.011 · Cited by 221
Roles of the human hypoxia-inducible factor (HIF)-3α variants in the hypoxia response
Heikkilä, M., Pasanen, A., Kivirikko, K. I., & Myllyharju, J. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0679-5 · Cited by 213
Glucose Transporters in Brain: In Health and in Alzheimer’s Disease
Szablewski, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160841 · Cited by 211 · cited 2×
“Conditional knockout of HIF-1 α in young adult mice led to neuronal alterations and a 40% reduction in TH expression in the substantia nigra [131,132].”
BackgroundThe Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia
Agani, F. H., Pichiule, P., Chavez, J. C., & LaManna, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005643200 · Cited by 210
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13932 · Cited by 205
Elzoghby, A. O., Abdelmoneem, M. A., Hassanin, I. A., Abd Elwakil, M. M., Elnaggar, M. A., Mokhtar, S., Fang, J.-Y., & Elkhodairy, K. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120355 · Cited by 203
Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Zhang, Z., Yan, J., Chang, Y., ShiDu Yan, S., & Shi, H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200426 · Cited by 189
Pathological role of hypoxia in Alzheimer's disease
Zhang, X., & Le, W. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.033 · Cited by 188
Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
Cascella, R., & Cecchi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094914 · Cited by 185
Activation of Hypoxia-Inducible Factors Prevents Diabetic Nephropathy
Nordquist, L., Friederich-Persson, M., Fasching, A., Liss, P., Shoji, K., Nangaku, M., Hansell, P., & Palm, F. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090990 · Cited by 184
Nair, D., Dayyat, E. A., Zhang, S. X., Wang, Y., & Gozal, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019847 · Cited by 168
Chronic Intermittent Hypoxia/Reoxygenation Facilitate Amyloid-β Generation in Mice
Shiota, S., Takekawa, H., Matsumoto, S.-E., Takeda, K., Nurwidya, F., Yoshioka, Y., Takahashi, F., Hattori, N., Tabira, T., Mochizuki, H., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130419 · Cited by 159
Obstructive sleep apnea decreases central nervous system–derived proteins in the cerebrospinal fluid
Ju, Y. S., Finn, M. B., Sutphen, C. L., Herries, E. M., Jerome, G. M., Ladenson, J. H., Crimmins, D. L., Fagan, A. M., & Holtzman, D. M. (2016) · Annals of Neurology · doi:10.1002/ana.24672 · Cited by 159
Glucose metabolism and Alzheimer's disease
Schubert, D. A. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.02.003 · Cited by 148
Gurung, P., Li, B., Subbarao Malireddi, R. K., Lamkanfi, M., Geiger, T. L., & Kanneganti, T.-D. (2015) · Scientific Reports · doi:10.1038/srep14488 · Cited by 147
Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 146
Farr, A. C., & Xiong, M. P. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 146
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
Mitroshina, Е. V., Saviuk, M. O., Ponimaskin, E. G., & Vedunova, M. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703084 · Cited by 144
Self-citationSanjuán-Pla, A., Cervera, A. M., Apostolova, N., Garcia-Bou, R., Víctor, V. M., Murphy, M. P., & McCreath, K. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.088 · Cited by 135
Tacchini, L., Gammella, E., De Ponti, C., Recalcati, S., & Cairo, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800365200 · Cited by 132
Flashman, E., Davies, S. L., Yeoh, K. K., & Schofield, C. J. (2010) · Biochemical Journal · doi:10.1042/bj20091609 · Cited by 129
Xi, L., Taher, M., Yin, C., Salloum, F., & Kukreja, R. C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00422.2004 · Cited by 128
Lal, C., Ayappa, I. A., Ayas, N., Beaudin, A. E., Hoyos, C. M., Kushida, C. A., Kamińska, M., Mullins, A. E., Naismith, S. L., Osorio, R. S., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202205-380st · Cited by 123
Nontranscriptional Role of Hif-1α in Activation of γ-Secretase and Notch Signaling in Breast Cancer
Villa, J. C., Chiu, D., Brandes, A. H., Escorcia, F. E., Villa, C. H., Maguire, W. F., Hu, C.-J., de Stanchina, E., Simon, M. C., Sisodia, S. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.028 · Cited by 121
Guo, C., Yang, Z., Zhang, S., Chai, R., Han, X., Zhang, Y., Li, J., & Wang, Z. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.8 · Cited by 120
The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson’s Disease
Santos, D., Esteves, A. R., Silva, D. F., Januário, C., & Cardoso, S. M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8893-4 · Cited by 118
Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
Xu, S.-F., Zhang, Y.-H., Wang, S., Pang, Z.-Q., Fan, Y.-G., Li, J., Zhan-you, W., & Guo, C. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101090 · Cited by 117
Mullins, A. E., Kam, K., Parekh, A., Bubu, O. M., Osorio, R. S., & Varga, A. W. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105054 · Cited by 116
Milosevic, J., Maisel, M., Wegner, F., Leuchtenberger, J., Wenger, R. H., Gerlach, M., Storch, A., & Schwarz, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2482-06.2007 · Cited by 115
Weng, M., Xie, X., Liu, C., Lim, K.-L., Zhang, C.-W., & Li, L. (2018) · Parkinson's Disease · doi:10.1155/2018/9163040 · Cited by 111
Youdim, M. B. H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.1 · Cited by 108
Poststroke Induction of -Synuclein Mediates Ischemic Brain Damage
Kim, T., Mehta, S. L., Kaimal, B., Lyons, K., Dempsey, R. J., & Vemuganti, R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1241-16.2016 · Cited by 106
Merelli, A., Rodríguez, J. C. G., Folch, J., Regueiro, M. R., Camins, A., & Lazarowski, A. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180110130253 · Cited by 106
Astroglial Calcium Signaling in Aging and Alzheimer's Disease
Verkhratsky, A. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035188 · Cited by 99 · cited 1×
“The depolarization of senescent neurons induces an influx of Ca 2+ from the extracellular space, leading to excitotoxicity [27] Elevated Ca 2+ levels result in glutamate accumulation in the synaptic cleft, promoting the activation of postsynaptic AMPA/NMDA receptors, which further increases the…”
BackgroundLee, D. W., Rajagopalan, S., Siddiq, A., Gwiazda, R., Yang, L., Beal, M. F., Ratan, R. R., & Andersen, J. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000638 · Cited by 97
Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration
Szlufik, S., Kopeć, K., Szleszkowski, S., & Koziorowski, D. (2024) · Cells · doi:10.3390/cells13030286 · Cited by 94
Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson's Disease
Elfil, M., Bahbah, E. I., Attia, M. M., Eldokmak, M., & Koo, B. B. (2020) · Movement Disorders · doi:10.1002/mds.28412 · Cited by 92
Effect of intermittent hypoxia on long-term potentiation in rat hippocampal slices
Payne, R. S., Goldbart, A. D., Gozal, D., & Schurr, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.045 · Cited by 90
The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptide
Schubert, D., Soucek, T., & Blouw, B. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06712.x · Cited by 89
Hypoxia Induces Autophagic Cell Death through Hypoxia-Inducible Factor 1α in Microglia
Yang, Z., Zhao, T., Zou, Y., Zhang, J. H., & Feng, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096509 · Cited by 86
Kupershmidt, L., Amit, T., Bar-Am, O., Youdim, M. B. H., & Weinreb, O. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4279 · Cited by 85
O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease
Park, J., Lai, M. K. P., Arumugam, T. V., & Jo, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08584-0 · Cited by 85
Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease
Youdim, M. B. H., Kupershmidt, L., Amit, T., & Weinreb, O. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70032-4 · Cited by 82
NO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells
Zhou, J., Fandrey, J., Schümann, J., Tiegs, G., & Brüne, B. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00294.2002 · Cited by 81
Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease
Wang, Y., Huang, Z., Yuan, M., Feng, J., Cai, R.-L., Zou, Q., Pu, Y., Wang, S., Chen, F., Yi, W., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201448 · Cited by 81
Pathological Impacts of Chronic Hypoxia on Alzheimer’s Disease
Zhang, F., Niu, L., Li, S., & Le, W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00442 · Cited by 80
Pathological Consequences of Intermittent Hypoxia in the Central Nervous System
Zhang, S. X. L., Wang, Y., & Gozal, D. (2012) · Comprehensive physiology · doi:10.1002/cphy.c100060 · Cited by 78
Identification and biology of α‐secretase
Vingtdeux, V., & Marambaud, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07477.x · Cited by 78
What are the links between hypoxia and Alzheimer’s disease?
Lall, R., Mohammed, R., & Ojha, U. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s203103 · Cited by 77
Gal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9070-9 · Cited by 76
Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease
Feng, Y., Liu, T., Li, X.-Q., Liu, Y., Zhu, X., Jankovic, J. J., Pan, T.-H., & Wu, Y. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.014 · Cited by 75
Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
Liu, M.-F., Xue, Y., Liu, C., Liu, Y.-H., Diao, H.-L., Wang, Y., Pan, Y.-P., & Chen, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00835 · Cited by 72
The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment
Iyalomhe, O., Swierczek, S. I., Enwerem, N. Y., Chen, Y., Adedeji, M. O., Allard, J. S., Ntekim, O. E., Johnson, S. M., Hughes, K., Kurian, P., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0440-6 · Cited by 71
Avramovich‐Tirosh, Y., Bar‐Am, O., Amit, T., Youdim, M. B. H., & Weinreb, O. (2010) · Current Alzheimer Research · doi:10.2174/156720510791162403 · Cited by 70
Li, X., Cui, X., Chen, Y., Wu, T., Xu, H., Yin, H., & Wu, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00121 · Cited by 70
Kim, S. Y., & Yang, E. (2015) · Molecules · doi:10.3390/molecules201119717 · Cited by 69
Arias‐Cavieres, A., Khuu, M. A., Nwakudu, C. U., Barnard, J. E., Dalgin, G., & Garcia, A. J. (2020) · eNeuro · doi:10.1523/eneuro.0024-20.2020 · Cited by 69
The neurohormone orexin stimulates hypoxia-inducible factor-1 activity
Sikder, D. S., & Kodadek, T. J. (2007) · Genes & Development · doi:10.1101/gad.1584307 · Cited by 68
Liu, H., Qiu, H., Yang, J., Ni, J., & Le, W. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.019 · Cited by 67
A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
AESG, Hartl, D., May, P., Gu, W., Mayhaus, M., Pichler, S., Spaniol, C., Glaab, E., Bobbili, D. R., Antony, P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0091-8 · Cited by 66
Glymphatic system dysfunction in neurodegenerative diseases
Beschörner, N., & Nedergaard, M. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001252 · Cited by 66
Brain microvasculature and hypoxia-related proteins in Alzheimer's disease.
(2011) · PubMed Central · Cited by 65
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Raut, S., Bhalerao, A., Powers, M., Gonzalez, M., Mancuso, S., & Cucullo, L. (2023) · Cells · doi:10.3390/cells12162019 · Cited by 65 · cited 1×
“PD is characterized by mitochondrial deficits, including a reduced mitochondrial number and structural damage, alongside diminished activity of complex I of the mitochondrial respiratory chain, potentially mediated by α -synuclein [125–127].”
BackgroundAlexander, C., Li, T., Hattori, Y., Chiu, D., Frost, G. R., Jonas, L., Liu, C., Anderson, C. J., Wong, E., Park, L., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01676-7 · Cited by 64
Zhang, X., Li, Q., Cong, W., Mu, S., Zhan, R., Zhong, S., Zhao, M., Zhao, C., Kang, K., & Zhou, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102127 · Cited by 61
Ünal-Çevik, I., Özdemir, Y., Yemişçi, M., Lüle, S., Gürer, G., Can, A., Müller, V., Kahle, P. J., & Dalkara, T. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.170 · Cited by 60
Ishida, T., Nakao, S., Ueyama, T., Harada, Y., & Kawamura, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00117-8 · Cited by 60
Hambali, A., Kumar, J., Hashim, N. F. M., Maniam, S., Mehat, M. Z., Cheema, M. S., Mustapha, M., Adenan, M. I., Stanslas, J., & Hamid, H. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.712317 · Cited by 60
Xing, J., & Lu, J. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445643 · Cited by 59
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Pinilla, L. L., Ugun‐Klusek, A., Rutella, S., & Girolamo, L. A. D. (2021) · Biology · doi:10.3390/biology10080723 · Cited by 59
Sun, M., Zhou, T., Zhou, L., Chen, Q., Yu, Y., Yang, H., Zhong, K., Zhang, X., Xu, F., Cai, S., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110506 · Cited by 57
Melatonin reduces hippocampal β-amyloid generation in rats exposed to chronic intermittent hypoxia
Ng, K., Lau, C. G., & Fung, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.044 · Cited by 55
Astroglial Calcium Signalling in Alzheimer's Disease
Verkhratsky, A., Rodríguez-Arellano, J. J., Parpura, V., & Zorec, R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.088 · Cited by 55 · cited 1×
“Hypoxia can disrupt calcium homeostasis through the accumulation of A β , and subsequently, elevated levels of intracellular calcium can trigger cell death [26].”
BackgroundMuddapu, V. R., & Chakravarthy, V. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81185-9 · Cited by 55
Astara, K., Tsimpolis, A., Kalafatakis, K., Vavougios, G. D., Xiromerisiou, G., Dardiotis, E., Christodoulou, G. N., Samara, M. T., & Lappas, A. S. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111899 · Cited by 55
Hu, X., Rea, H. C., Wiktorowicz, J. E., & Perez-Polo, J. R. (2006) · Journal of Proteome Research · doi:10.1021/pr060209x · Cited by 53
Kerridge, C., Kozlova, D. I., Nalivaeva, N. N., & Turner, A. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00426 · Cited by 52
Physiological Role of Orexinergic System for Health
Villano, I., Marra, M. L., Maio, G. D., Monda, V., Chieffi, S., Guatteo, E., Messina, G., Moscatelli, F., Monda, M., & Messina, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148353 · Cited by 51
Wall, A. M., Corcoran, A. E., O’Halloran, K. D., & O'Connor, J. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.016 · Cited by 49
Regulation of the VHL/HIF-1 Pathway by DJ-1
Parsanejad, M. E., Zhang, Y., Qu, D., Irrcher, I., Rousseaux, M. W. C., Aleyasin, H., Kamkar, F., Callaghan, S. M., Slack, R. S., Mak, T. W., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1244-13.2014 · Cited by 48
Xie, L., Zhang, N., Zhang, Q., Li, C., Sandhu, A. F., III, G. W., Lin, S., Lv, P., Liu, Y., Wu, Q., et al. (2020) · Aging · doi:10.18632/aging.103663 · Cited by 48
Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia.
Lv, B., Li, F., Fang, J., Xu, L., Sun, C., Han, J., Hua, T., Zhang, Z., Feng, Z., & Jiang, X. (2017) · PubMed · Cited by 47
Expression of glucose transporters in human neurodegenerative diseases
Głuchowska, K., Pliszka, M., & Szablewski, L. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.067 · Cited by 47
Neurodegenerative Erkrankungen
Reith, W. (2018) · Der Radiologe · doi:10.1007/s00117-018-0363-y · Cited by 46
Selvaraju, V., Parinandi, N. L., Adluri, R. S., Goldman, J. W., Hussain, N., Sanchez, J. A., & Maulik, N. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5186 · Cited by 45
An immunohistochemical study of centenarian brains: a comparison
Itoh, Y., Yamada, M., Suematsu, N., Matsushita, M., & Otomo, E. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00050-1 · Cited by 45
Zakharova, E. T., Kostevich, V. A., Av, S., & Vasilyev, V. B. (2012) · BioMetals · doi:10.1007/s10534-012-9586-y · Cited by 45
Zhang, G., Chen, L., Liu, J., Jin, Y., Lin, Z., Du, S., Fu, Z., Chen, T., Qin, Y., Sui, F., et al. (2020) · Aging · doi:10.18632/aging.102636 · Cited by 44
Shin, D. H., Li, S. H., Yang, S., Lee, B. L., Lee, M. K., & Park, J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07069.x · Cited by 43
Solovyev, N. D., El‐Khatib, A. H., Costas‐Rodríguez, M., Schwab, K., Griffin, E., Raab, A., Platt, B., Theuring, F., Vogl, J., & Vanhaecke, F. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100292 · Cited by 43
Ling, L., Feng, J., Wu, G., Wei, Z. C., Wang, J., Zhang, B., Liu, R., Liu, F., Wang, X., & Li, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416140 · Cited by 43
Petralla, S., Saveleva, L., Kanninen, K. M., Oster, J. S., Panayotova, M., Fricker, G., & Puris, E. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03990-3 · Cited by 42
Guo, M., Ji, X., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.919343 · Cited by 41
Mechlovich, D., Amit, T., Bar-Am, O., Mandel, S., Youdim, M., & Weinreb, O. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131212112529 · Cited by 40
Macheda, T., Roberts, K. N., Lyons, D. N., Higgins, E. K., Ritter, K. J., Lin, A., Alilain, W. J., & Bachstetter, A. D. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.040 · Cited by 40
Chronic hypoxia of endothelial cells boosts HIF-1α-NLRP1 circuit in Alzheimer’s disease
Jung, E., Kim, Y. E., Jeon, H. S., Yoo, M., Kim, M., Kim, Y., Koh, S., & Choi, Y. K. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.05.011 · Cited by 40
Amit, T., Bar‐Am, O., Mechlovich, D., Kupershmidt, L., Youdim, M. B. H., & Weinreb, O. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.026 · Cited by 39
Plasma α ‐synuclein levels are increased in patients with obstructive sleep apnea syndrome
Sun, H., Sun, B., Chen, D., Chen, Y., Li, W., Xu, M., Shen, Y., Xu, Z., Wang, Y., & Bu, X. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.756 · Cited by 37
Zhang, Y., Yan, X.-Z., Xu, S., Pang, Z., Li, L., Yang, Y., Fan, Y., Wang, Z., Yu, X., Guo, C., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00262 · Cited by 37
A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis
Sun, Y., Chai, X., Kong, W., Liu, L., Yu, W., & Zhang, Z. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.135317 · Cited by 36
Wohlrab, C., Kuiper, C., Vissers, M. C. M., Phillips, E., Robinson, B. A., & Dachs, G. U. (2019) · Hypoxia · doi:10.2147/hp.s201643 · Cited by 36
Shimizu, S., Takenoshita, N., Inagawa, Y., Tsugawa, A., Hirose, D., Kaneko, Y., Ogawa, Y., Serisawa, S., Sakurai, S., Hirao, K., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190958 · Cited by 36
When the Brain Yearns for Oxygen
Leu, T., Schützhold, V., Fandrey, J., & Ferenz, K. B. (2019) · Neurosignals · doi:10.33594/000000199 · Cited by 32
Wan, X., Liu, Y., Zhao, Y., Sun, X., Fan, D., & Guo, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184213 · Cited by 30
HIF-1α serves as a co-linker between AD and T2DM
Yang, H. T., Ren, K., Zhang, Y., Yang, L., Cao, H., Yuan, X., Su, L., Li, H., Feng, X., & Liu, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116158 · Cited by 29
Auerbach, I. D., & Vinters, H. V. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00009 · Cited by 27
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
Agüero, P., Sainz, M. J., García‐Ayllón, M., Sáez‐Valero, J., Téllez, R., Guerrero, R., Pérez‐Pérez, J., Jiménez‐Escrig, A., & Gómez‐Tortosa, E. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00708-0 · Cited by 27
Fatal attraction – The role of hypoxia when alpha-synuclein gets intimate with mitochondria
Burtscher, J., Syed, M. M. K., Keller, M. A., Lashuel, H. A., & Millet, G. P. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.017 · Cited by 26
Chen, T., Wang, Q., Chao, D., Xia, T. C., Sheng, S., Li, Z.-R., Zhao, J., Wen, G., Ding, G., & Xia, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1316-1 · Cited by 25
Epidemiology of Dementia in China in 2010–2020: A Systematic Review and Meta-Analysis
Yin, Y., Tam, H. L., Quint, J. K., Chen, M., Ding, R., & Zhang, X. (2024) · Healthcare · doi:10.3390/healthcare12030334 · Cited by 24
Roxadustat: Do we know all the answers?
Li, Q., Xiong, Q.-W., Yao, X., Liu, F., Tang, X., Fu, H., Tong, T., Mao, J., & Peng, W. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2022.8437 · Cited by 23
γ-Secretase Modulatory Proteins: The Guiding Hand Behind the Running Scissors
Wong, E., Frost, G. R., & Li, Y.-M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.614690 · Cited by 22
Gabryelska, A., & Sochal, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314876 · Cited by 22
Alzheimer’s Disease, Sleep Disordered Breathing, and Microglia: Puzzling out a Common Link
Ulland, T. K., Ewald, A. C., Knutson, A. O., Marino, K. M., Smith, S. M. C., & Watters, J. J. (2021) · Cells · doi:10.3390/cells10112907 · Cited by 21
Rybnikova, E. A., Gluschenko, T. S., Galeeva, A., Tyulkova, E. I., Nalivaeva, N. N., Makova, N. Z., Turner, A. J., & Самойлов, М. О. (2012) · Neuroscience Research · doi:10.1016/j.neures.2011.12.010 · Cited by 20
Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105186 · Cited by 20
Zhao, P., You, Y., Wang, Z., Zhou, Y., Chai, G., Yan, G., Jin, Z., Wang, Q., & Sun, H. (2022) · Brain Structure and Function · doi:10.1007/s00429-021-02447-w · Cited by 19
Chinta, S. J., Rajagopalan, S., Ganesan, A., & Andersen, J. K. (2012) · Parkinson s Disease · doi:10.1155/2012/364684 · Cited by 18
Calvo-Rodríguez, M., Kharitonova, E. K., & Bacskai, B. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118998 · Cited by 18
Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure
Pena, E., Martin-Salamanca, R. S., Alam, S. E., Flores, K., & Arriaza, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020889 · Cited by 18
Parandavar, E., & Yazdanparast, R. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0180-4 · Cited by 14
Hypoxia induces HT-22 neuronal cell death via Orai1/CDK5 pathway-mediated Tau hyperphosphorylation.
Fang, B., Zhao, Q., Ling, W.-M., Zhang, Y., & Ou, M. (2019) · Europe PMC (PubMed Central) · Cited by 14
Guo, M., Liu, W., Luo, H., Shao, Q., Li, Y., Gu, Y., Guan, Y., Ma, W., Chen, M., Yang, H., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14055 · Cited by 14
Degradation of the Hypoxia-Inducible Factor 1α, Where Does it Happen?
Pereira, T., Zheng, X., & Poellinger, L. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3536 · Cited by 13
Gu, H., Ru, Y., Wang, W., Cai, G., Gu, L., Ye, J., Zhang, W., & Wang, L. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s363286 · Cited by 13
Ma, X., Wang, X., Cao, J., Geng, Z., & Wang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095692 · Cited by 11
Chun, Y. S., Cho, Y. Y., Kwon, O.-H., Zhao, D. F., Yang, H. O., & Chung, S. (2020) · Molecules · doi:10.3390/molecules25030646 · Cited by 9
Intermittent hypoxia produces Alzheimer disease?
Yagishita, S., & Hirasawa, A. (2017) · Oncotarget · doi:10.18632/oncotarget.18214 · Cited by 8
Gupta, S., Jinka, S. K. A., Khanal, S., Bhavnani, N., Almashhori, F., Lallo, J., Mathias, A., Al‐Rhayyel, Y., Herman, D. E., Holden, J. G., et al. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25196 · Cited by 8
[Neuropathology of the cerebral vessels of centenarians].
Hauw, J., Zekry, D., Seilhean, D., et al. (2002) · PubMed · Cited by 7
[Neuropathology of the cerebral vessels of centenarians].
Hauw, J., Zekry, D., Seilhean, D., Forette, B., Gallinari, C., Laurent, M., Moulias, R., Piette, F., Sachet, A., & Duyckaerts, C. J. (2002) · PubMed · Cited by 7
Cao, R., Du, F., Cui, Y., Qi, M., Zhuang, J., Wang, J., Zhang, M., Zhang, X., Liu, Z., Zou, L., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107064 · Cited by 6
Muñoz, A. R., Fernández-Pérez, E. J., Olivos, N., Burgos, C. F., Boopathi, S., Armijo‐Weingart, L., Pacheco, C. R., González, W., & Aguayo, L. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413253 · Cited by 2
Obstructive sleep apnea and amyloid-β42 in adolescents: The results of a pilot study
Berdina, O. N., Михайловна, М. И., Bolshakova, S. E., Sholokhov, L. F., & Rychkova, L. V. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.3.2
Research works printed but not linked: 2
- Tarkowska A. Hypoxic-Ischemic Brain Injury after Perinatal Asphyxia as a Possible Factor in the Pathology of Alzheimer’s Disease Cerebral Ischemia Exon Publications Brisbane, QLD, Australia 2021 45 60 34905310
- Sethuraman A. Rao P. Pranay A. Xu K. LaManna J.C. Puchowicz M.A. Chronic Ketosis Modulates HIF1α-Mediated Inflammatory Response in Rat Brain Oxygen Transport to Tissue XLII Springer Berlin/Heidelberg, Germany 2021 3 7
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
Nisar, A., Khan, S., Li, W., Hu, L., Samarawickrama, P. N., Gold, N. M., Zi, M., Mehmood, S. A., Miao, J., & He, Y. (2024) · MedComm · doi:10.1002/mco2.786 · Cited by 37
Jalouli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041752 · Cited by 34
Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
Lin, T., Huang, C.-R., Lin, K.-J., Hsieh, Y.-H., Chen, S., Lin, Y., Chao, A., & Yang, D. (2024) · Antioxidants · doi:10.3390/antiox13111378 · Cited by 34
Porel, P., Bala, K., & Aran, K. R. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01585-x · Cited by 28
Metadata
- Authors
- Mitroshina, E. V., & Vedunova, M. V.
- Affiliations
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 23 Gagarin Avenue, 603022 Nizhny Novgorod, Russia
- N. I. Lobachevsky State University of Nizhny Novgorod (RU)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-04-23
- Volume
- 25
- Issue
- 9
- Pages
- 4581
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC11083463
- OpenAlex
- W4395043914
- Cited by
- 48
- References
- 177
- Citations by year
- 2026: 27 · 2025: 13 · 2024: 8
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Russian Science Foundation (RSF) (22-15-00178)
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oxygen homeostasis, hypoxia, HIF-1, HIF-1α, neurodegeneration, Alzheimer's disease, Parkinson's disease, pathogenesis, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Hypoxia, Homeostasis, Humans, Oxygen, Parkinson Disease, Neurodegenerative Diseases, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.